Back to Market Feed

Historical record - last NADAC effective date: 11/19/2014

Product Information

ZIDOVUDINE 100 MG CAPSULE is a generic product labeled by Aurobindo Pharma Limited, priced at $1.3658 per EA under NDC 65862010701. Its NADAC has been published 108 times since Nov 28, 2013.

FDA first approved this application on Mar 27, 2006. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ZIDOVUDINE 100 MG CAPSULE

Zidovudine
$1.3658per EA

Strength

100 mg/1

NDC

65862010701

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

11/19/2014

Active Ingredients

ZIDOVUDINE

Approval Type

Generic (ANDA)

FDA Application

ANDA078128

FDA Approved

3/27/2006

TE Code

AB

On Market Since

3/27/2006

Pharmacological Classes

Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Nucleoside Reverse Transcriptase Inhibitors

Price Statistics

The NADAC for ZIDOVUDINE 100 MG CAPSULE has been published 108 times since Nov 28, 2013, and over the history we have for it it has risen 2.7%. The table below summarizes its recorded NADAC range and movement.

Current price$1.3658 per EA
All-time high$1.3658 (Dec 16, 2015)
All-time low$1.2475 (Jan 22, 2014)
Median price$1.3658
Average price$1.3161
Largest weekly change+9.5% (Nov 19, 2014)
Weeks tracked108
Tracking sinceNov 28, 2013

Price History

1W

N/A

1M

N/A

3M

N/A

6M

N/A

1Y

N/A

3Y

N/A

5Y

N/A

All

+2.7%

Last surveyed Dec 16, 2015 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Zidovudine market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

NEVIRAPINE 200 MG TABLET
Generic
65862002760•Aurobindo Pharma Limited
$0.1314
per EA
NEVIRAPINE 200 MG TABLET
Generic
00378405091•Mylan Pharmaceuticals Inc.
$0.1469
per EA
NEVIRAPINE 200 MG TABLET
Generic
31722050560•Camber Pharmaceuticals Inc.
$0.1469
per EA
NEVIRAPINE 200 MG TABLET
Generic
33342000409•Macleods Pharmaceuticals Limited
$0.1469
per EA
NEVIRAPINE 200 MG TABLET
Generic
65162020906•Amneal Pharmaceuticals LLC
$0.1556
per EA
ENTECAVIR 0.5 MG TABLET
Generic
16714071701•NorthStar Rx LLC
$0.2134
per EA
ENTECAVIR 0.5 MG TABLET
Generic
31722083330•Camber Pharmaceuticals Inc.
$0.2134
per EA
ENTECAVIR 0.5 MG TABLET
Generic
31722083390•Camber Pharmaceuticals Inc.
$0.2134
per EA
ENTECAVIR 0.5 MG TABLET
Generic
42494045730•Cameron Pharmaceuticals
$0.2134
per EA
ENTECAVIR 0.5 MG TABLET
Generic
42806065830•Epic Pharma LLC
$0.2134
per EA

Frequently asked questions

What is the NADAC price of ZIDOVUDINE 100 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for ZIDOVUDINE 100 MG CAPSULE, manufactured by Aurobindo Pharma Limited, is $1.3658 per EA (NDC 65862010701), effective Dec 16, 2015.

How has the price of ZIDOVUDINE 100 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for ZIDOVUDINE 100 MG CAPSULE has risen 2.7%. It has been tracked across 108 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for ZIDOVUDINE 100 MG CAPSULE?

Since Nov 28, 2013, the NADAC for ZIDOVUDINE 100 MG CAPSULE has ranged from a low of $1.2475 (Jan 22, 2014) to a high of $1.3658 (Dec 16, 2015), with a median of $1.3658 per EA.

Are there cheaper alternatives to ZIDOVUDINE 100 MG CAPSULE?

No other NADAC-published product currently shares the active ingredient and strength of ZIDOVUDINE 100 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures ZIDOVUDINE 100 MG CAPSULE?

ZIDOVUDINE 100 MG CAPSULE (NDC 65862010701) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.